U.S. Opioids Market Huge Growth in Future Scope 2021-2028 | Purdue Pharma L.P., Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH

"U.S. Opioids Market, Drug Price, Sales and Clinical Trials Insight 2028” Report Highlights:

U.S. Opioids Market Opportunity: > US$ 18,985.4 Million by 2028

U.S. Opioids Market Growth: 100% Absolute Growth Till 2028

U.S. Opioids Market Size Opportunity by Therapeutic Class

Insight On Clinical Trials by Company, Indication, Patient Segment and Phase

Total Number of Pages in this Report: 132

Overview

Doctors routinely prescribe opioids like oxycodone, hydromorphone, and hydrocodone to treat either acute pain caused by an accident or chronic pain caused by chronic disease like arthritis. While opioids can reduce pain for some patients immediately after a severe injury or surgery, there is no evidence that they control pain long term, especially when opioids are used incorrectly or when combination pain killers are used. Some studies have even shown that long-term use of powerful narcotics may be dangerous. Doctors and pharmacists know that most people will want to take the pain killers long term and they don't recommend long term use of any pain medication for minor, acute pain.

Market Statistics:

The U.S. opioids market was valued at US$ 12,627.6 million in 2016 and is expected to exhibit CAGR of 5.2% over the forecast period (2016–2024).

U.S. Opioids Market: Drivers

High incidence of HIV is expected to propel growth of the U.S. opioids market over the forecast period. For instance, according to ‘Summary: Estimates of HIV incidence, prevalence and Canada’s progress on meeting the 90-90-90 HIV targets, 2016’ published by Public Health Agency of Canada, in July 2018, in 2016, 63,110 people in Canada were infected with HIV.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1048

U.S. Opioids Market: Opportunities

R&D in use of synthetic opioids is expected to offer lucrative growth opportunities for players in the U.S. opioids market. For instance, in March 2020, Adamis Pharmaceuticals Corporation, in collaboration with University of Michigan, U.S., reported that higher doses of 2 mg intramuscular Naloxone result in higher mu receptor occupancy and could be useful in addressing overdoses resulting from potent synthetic opioids.

U.S. Opioids Market: Restraints

Strict regulatory guidelines for opioids prescription and increasing substance abuse is expected ti limit growth of the U.S. opioids market. For instance, in October 2017, Government of the U.S. declared the opioid crisis, as a public health emergency. Moreover, according to the National Center for Health Statistics (NCHS), a division of the Centers for Disease Control and Prevention, (CDC) in 2017, drug overdose killed around 64,070 people in the U.S. in 2016, a rise of 21% over the 52,898 drug overdose deaths was recorded in 2015 and death due to synthetic-opioid fatalities more than doubling in number during the same time increasing from 9,945 in 2015 -2016 to 20,145 in 2016 - 2017.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1048

Covid-19 Impact Analysis:

In United States of America, from 3 January 2020 to 5:09pm CEST, 18 October 2021, there have been 44,408,612 confirmed cases of COVID-19 with 715,179 deaths, reported to WHO. As of 14 October 2021, a total of 416,110,353 vaccine doses have been administered.

The emergence of Covid-19 has led to increase in cases of drug overdoses. COVID-19 has tripled the rate of depression in US adults in all demographic groups—especially in those with financial worries. Such scenario has led the U.S. Department of Health and Human Services to relax a regulation around prescribing addiction medication in an effort to combat the rising death toll.

Key Takeaways:

The U.S. Opioids market is expected to exhibit a CAGR of 5.2% over the forecast period (2017 – 2025), owing to the increasing incidences of chronic pain, especially in emerging economies.

U.S. Opioids Market: Competitive Landscape

Major players operating in the U.S. opioids market include, Allergan, plc, Boehringer Ingelheim GmbH, Egalet Corporation, Endo Pharmaceuticals plc, Janssen Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceuticals Industries Limited, and Titan Pharmaceuticals, Inc.

Get Flat USD 2000 OFF On Direct Purchase

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1048

Table of Contents:
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis

4. U.S. Opioids Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

5. U.S. Opioids Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

6. U.S. Opioids Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

7. U.S. Opioids Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.